These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32573488)

  • 1. Single-cell repertoire tracing identifies rituximab-resistant B cells during myasthenia gravis relapses.
    Jiang R; Fichtner ML; Hoehn KB; Pham MC; Stathopoulos P; Nowak RJ; Kleinstein SH; O'Connor KC
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody-producing plasmablasts after B cell depletion identified in muscle-specific kinase myasthenia gravis.
    Stathopoulos P; Kumar A; Nowak RJ; O'Connor KC
    JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis.
    Stathopoulos P; Kumar A; Heiden JAV; Pascual-Goñi E; Nowak RJ; O'Connor KC
    Ann N Y Acad Sci; 2018 Jan; 1412(1):154-165. PubMed ID: 29381221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reemergence of pathogenic, autoantibody-producing B cell clones in myasthenia gravis following B cell depletion therapy.
    Fichtner ML; Hoehn KB; Ford EE; Mane-Damas M; Oh S; Waters P; Payne AS; Smith ML; Watson CT; Losen M; Martinez-Martinez P; Nowak RJ; Kleinstein SH; O'Connor KC
    Acta Neuropathol Commun; 2022 Oct; 10(1):154. PubMed ID: 36307868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.
    Zografou C; Vakrakou AG; Stathopoulos P
    Front Immunol; 2021; 12():686466. PubMed ID: 34220839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen specific B cells in myasthenia gravis patients.
    Takata K; Kinoshita M; Mochizuki H; Okuno T
    Immunol Med; 2020 Jun; 43(2):65-71. PubMed ID: 32046601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longstanding and Refractory Anti-Muscle Specific Tyrosine Kinase Antibody-Associated Myasthenia Gravis (Anti-MuSK-MG) in a Child Successfully Treated with Rituximab.
    Weger S; Appendino JP; Clark IH
    J Binocul Vis Ocul Motil; 2019; 69(1):26-29. PubMed ID: 30811277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients.
    Keung B; Robeson KR; DiCapua DB; Rosen JB; O'Connor KC; Goldstein JM; Nowak RJ
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1407-9. PubMed ID: 23761915
    [No Abstract]   [Full Text] [Related]  

  • 9. Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).
    Çebi M; Durmuş H; Yılmaz V; Yentür SP; Aysal F; Oflazer P; Parman Y; Deymeer F; Saruhan-Direskeneli G
    Clin Exp Immunol; 2019 Aug; 197(2):214-221. PubMed ID: 30929252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody.
    Zhou Y; Yan C; Gu X; Zhou L; Lu J; Zhu W; Huan X; Luo S; Zhong H; Lin J; Lu J; Zhao C; Xi J
    Muscle Nerve; 2021 Jun; 63(6):824-830. PubMed ID: 33745138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Lasting Rituximab-Induced Reduction of Specific-But Not Total-IgG4 in MuSK-Positive Myasthenia Gravis.
    Marino M; Basile U; Spagni G; Napodano C; Iorio R; Gulli F; Todi L; Provenzano C; Bartoccioni E; Evoli A
    Front Immunol; 2020; 11():613. PubMed ID: 32431692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between musk antibody concentrations and the myasthenia gravis composite score in 3 patients: A marker of relapse?
    Triplett JD; Hardy TA; Riminton DS; Chu SYK; Reddel SW
    Muscle Nerve; 2019 Sep; 60(3):307-311. PubMed ID: 31177576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.
    Hain B; Jordan K; Deschauer M; Zierz S
    Muscle Nerve; 2006 Apr; 33(4):575-80. PubMed ID: 16323216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.
    Lazaridis K; Tzartos SJ
    Front Immunol; 2020; 11():212. PubMed ID: 32117321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.
    Beecher G; Putko BN; Wagner AN; Siddiqi ZA
    Drugs; 2019 Mar; 79(4):353-364. PubMed ID: 30762205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL; Gooch CL
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use and monitoring of low dose rituximab in myasthenia gravis.
    Blum S; Gillis D; Brown H; Boyle R; Henderson R; Heyworth-Smith D; Hogan P; Kubler P; Lander C; Limberg N; Pillans P; Prain K; Staples C; Walsh M; McCombe P; Wong R
    J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):659-63. PubMed ID: 21071753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab as Adjunct Maintenance Therapy for Refractory Juvenile Myasthenia Gravis.
    Zingariello CD; Elder ME; Kang PB
    Pediatr Neurol; 2020 Oct; 111():40-43. PubMed ID: 32951658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis.
    Lebrun C; Bourg V; Bresch S; Cohen M; Rosenthal-Allieri MA; Desnuelle C; Ticchioni M
    J Neuroimmunol; 2016 Sep; 298():79-81. PubMed ID: 27609279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis with antibodies to MuSK: an update.
    Evoli A; Alboini PE; Damato V; Iorio R; Provenzano C; Bartoccioni E; Marino M
    Ann N Y Acad Sci; 2018 Jan; 1412(1):82-89. PubMed ID: 29266255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.